Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Tuberculosis
Related studies linked through entity extraction aliases.
Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town
- Status
- COMPLETED
- Phase
- PHASE1
Diagnosis of Active and Latent TB Infection With IFN-y Assays in African Children
- Status
- UNKNOWN
- Phase
- N/A
Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.
- Status
- COMPLETED
- Phase
- PHASE1
TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Trial of a LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine (Ag85B-ESAT6)
- Status
- TERMINATED
- Phase
- PHASE1
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously
- Status
- COMPLETED
- Phase
- PHASE1
Metronidazole for Pulmonary Tuberculosis (South Korea)
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.
- Status
- COMPLETED
- Phase
- PHASE1
A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infection
- Status
- WITHDRAWN
- Phase
- PHASE3
Investigation of a Novel Approach to Improve Treatment Success Rates for Tuberculosis Patients in Senegal
- Status
- COMPLETED
- Phase
- PHASE4
The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage
- Status
- COMPLETED
- Phase
- PHASE4
A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy
- Status
- COMPLETED
- Phase
- PHASE4
Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver Disease
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 0,1 Months to Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE2
Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection
- Status
- TERMINATED
- Phase
- PHASE4